O'Day SJ - Search Results

1

Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.

Lin SY, Chang SC, Lam S, Irene Ramos R, Tran K, Ohe S, Salomon MP, Bhagat AAS, Teck Lim C, Fischer TD, Foshag LJ, Boley CL, O'Day SJ, Hoon DSB. Lin SY, et al. Among authors: o day sj. Clin Chem. 2020 Jan 1;66(1):169-177. doi: 10.1373/clinchem.2019.307140. Clin Chem. 2020. PMID: 31672856 Free PMC article.

2

Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma.

O'Day SJ, Gammon G, Boasberg PD, Martin MA, Kristedja TS, Guo M, Stern S, Edwards S, Fournier P, Weisberg M, Cannon M, Fawzy NW, Johnson TD, Essner R, Foshag LJ, Morton DL. O'Day SJ, et al. J Clin Oncol. 1999 Sep;17(9):2752-61. doi: 10.1200/JCO.1999.17.9.2752. J Clin Oncol. 1999. PMID: 10561350

3

The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.

Taback B, Morton DL, O'Day SJ, Nguyen DH, Nakayama T, Hoon DS. Taback B, et al. Recent Results Cancer Res. 2001;158:78-92. doi: 10.1007/978-3-642-59537-0_8. Recent Results Cancer Res. 2001. PMID: 11092035 Review.

4

Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patients.

Hoon DS, Kuo CT, Wascher RA, Fournier P, Wang HJ, O'Day SJ. Hoon DS, et al. J Invest Dermatol. 2001 Aug;117(2):375-8. doi: 10.1046/j.0022-202x.2001.01417.x. J Invest Dermatol. 2001. PMID: 11511319 Free article.

5

Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on Cancer stage II melanoma patients receiving adjuvant polyvalent vaccine.

DiFronzo LA, Gupta RK, Essner R, Foshag LJ, O'Day SJ, Wanek LA, Stern SL, Morton DL. DiFronzo LA, et al. J Clin Oncol. 2002 Aug 1;20(15):3242-8. doi: 10.1200/JCO.2002.01.065. J Clin Oncol. 2002. PMID: 12149297

6

Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.

Morton DL, Hsueh EC, Essner R, Foshag LJ, O'Day SJ, Bilchik A, Gupta RK, Hoon DS, Ravindranath M, Nizze JA, Gammon G, Wanek LA, Wang HJ, Elashoff RM. Morton DL, et al. Ann Surg. 2002 Oct;236(4):438-48; discussion 448-9. doi: 10.1097/00000658-200210000-00006. Ann Surg. 2002. PMID: 12368672 Free PMC article. Clinical Trial.

7

Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine.

Hsueh EC, Essner R, Foshag LJ, Ollila DW, Gammon G, O'Day SJ, Boasberg PD, Stern SL, Ye X, Morton DL. Hsueh EC, et al. J Clin Oncol. 2002 Dec 1;20(23):4549-54. doi: 10.1200/JCO.2002.01.151. J Clin Oncol. 2002. PMID: 12454111 Clinical Trial.

8

Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma.

Taback B, O'Day SJ, Boasberg PD, Shu S, Fournier P, Elashoff R, Wang HJ, Hoon DS. Taback B, et al. J Natl Cancer Inst. 2004 Jan 21;96(2):152-6. doi: 10.1093/jnci/djh011. J Natl Cancer Inst. 2004. PMID: 14734706 Free PMC article.

9

Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome.

Fujimoto A, O'Day SJ, Taback B, Elashoff D, Hoon DS. Fujimoto A, et al. Cancer Res. 2004 Jun 15;64(12):4085-8. doi: 10.1158/0008-5472.CAN-04-0957. Cancer Res. 2004. PMID: 15205316

10

Quantification of circulating DNA in the plasma and serum of cancer patients.

Taback B, O'Day SJ, Hoon DS. Taback B, et al. Ann N Y Acad Sci. 2004 Jun;1022:17-24. doi: 10.1196/annals.1318.004. Ann N Y Acad Sci. 2004. PMID: 15251934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page